Acute hormonal and renal effects of oral dilevalol in normal men
- PMID: 2523264
- DOI: 10.1111/j.1440-1681.1989.tb01909.x
Acute hormonal and renal effects of oral dilevalol in normal men
Abstract
1. Acute hormonal and renal effects of dilevalol (200 mg), a non-selective beta-blocking drug with vasodilator properties, were compared with placebo in six normal men on constant sodium intake. 2. Control and treatment blood pressures were lower with dilevalol than placebo, although the pattern of blood pressure fall was similar in both. 3. Plasma active renin and aldosterone concentrations were lower on dilevalol than placebo after 4 h of recumbency (P less than 0.05). 4. Total plasma renin, renin substrate, cortisol and atrial natriuretic peptide concentrations were similar on dilevalol and placebo. 5. There were no differences in glomerular filtration rate and no deleterious biochemical or haematological changes on dilevalol or placebo.
Similar articles
-
Clinical pharmacology of dilevalol (I). Comparison of the pharmacokinetic and pharmacodynamic properties of dilevalol and labetalol after a single oral administration in healthy subjects.J Clin Pharmacol. 1989 Jul;29(7):635-42. doi: 10.1002/j.1552-4604.1989.tb03392.x. J Clin Pharmacol. 1989. PMID: 2668352
-
Effects of dilevalol, an R, R-isomer of labetalol, on blood pressure and renal function in patients with mild-to-moderate essential hypertension.Eur J Clin Pharmacol. 1988;35(1):9-15. doi: 10.1007/BF00555500. Eur J Clin Pharmacol. 1988. PMID: 2905992 Clinical Trial.
-
Comparison of intravenous dilevalol with placebo in moderate hypertension.Clin Pharmacol Ther. 1989 Oct;46(4):445-50. doi: 10.1038/clpt.1989.163. Clin Pharmacol Ther. 1989. PMID: 2551560 Clinical Trial.
-
Dilevalol: a selective beta-2 adrenergic agonist vasodilator with beta adrenergic blocking activity.J Clin Pharmacol. 1989 Dec;29(12):1057-68. doi: 10.1002/j.1552-4604.1989.tb03280.x. J Clin Pharmacol. 1989. PMID: 2693499 Review.
-
Clinical pharmacokinetics and kinetic-dynamic relationships of dilevalol and labetalol.Clin Pharmacokinet. 1991 Aug;21(2):95-109. doi: 10.2165/00003088-199121020-00002. Clin Pharmacokinet. 1991. PMID: 1884570 Review.
Cited by
-
Dilevalol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in hypertension.Drugs. 1990 Feb;39(2):234-63. doi: 10.2165/00003495-199039020-00007. Drugs. 1990. PMID: 2184002 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical